Aurora Spine Corp. engages in the development and distribution of spinal implant products. The company is headquartered in Toronto, Ontario. The company went IPO on 2013-09-10. The Company’s products generally fall into three product lines: interspinous process (ISP) lumbar fusion devices, Stand-alone (SA) Cervical and Lumbar fusion cages, and SI joint fusion devices. Its ISP lumbar fusion devices include the ZIP, the ZIP ULTR, the ZIP LP and the ZIP-51. The company also offers a line of interbody products: Discovery for cervical procedures; SOLO, an ALIF 3D-printed stand-alone lumbar fusion device; SiLO, a posterior allograft implant; and SiLO TFX, a titanium implant device, both for sacroiliac (SI) joint fusion, and Dexa-C a 3D printed cervical fusion device which is paired with the Apollo cervical plate. In addition, the Company markets certain third-party-developed products used during spine surgeries (i.e. surgical screws and bone growth biologic materials).
Aurora Spine Corp 주요 수익원은 Hospitals and Ambulatory Surgery Centers이며, 최신 수익 발표에서 수익은 22,660,047입니다. 지역별로는 United States이 Aurora Spine Corp의 주요 시장이며, 수익은 24,060,337입니다.